DK0531981T3 - Fremgangsmåde til fremstilling af et cephalosporin-antibitiotikum - Google Patents

Fremgangsmåde til fremstilling af et cephalosporin-antibitiotikum

Info

Publication number
DK0531981T3
DK0531981T3 DK92115443T DK92115443T DK0531981T3 DK 0531981 T3 DK0531981 T3 DK 0531981T3 DK 92115443 T DK92115443 T DK 92115443T DK 92115443 T DK92115443 T DK 92115443T DK 0531981 T3 DK0531981 T3 DK 0531981T3
Authority
DK
Denmark
Prior art keywords
preparation
isomer
methyl
cephalosporin antibiotic
antibiotic
Prior art date
Application number
DK92115443T
Other languages
Danish (da)
English (en)
Inventor
Gary M F Lim
John M Roubie
Elizabeth Ann Garofalo
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0531981T3 publication Critical patent/DK0531981T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Revetment (AREA)
  • Artificial Fish Reefs (AREA)
DK92115443T 1991-09-10 1992-09-09 Fremgangsmåde til fremstilling af et cephalosporin-antibitiotikum DK0531981T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75710491A 1991-09-10 1991-09-10

Publications (1)

Publication Number Publication Date
DK0531981T3 true DK0531981T3 (da) 2002-05-21

Family

ID=25046366

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92115443T DK0531981T3 (da) 1991-09-10 1992-09-09 Fremgangsmåde til fremstilling af et cephalosporin-antibitiotikum

Country Status (29)

Country Link
EP (1) EP0531981B1 (no)
JP (1) JP3434840B2 (no)
KR (1) KR0178280B1 (no)
CN (2) CN1036587C (no)
AT (1) ATE209209T1 (no)
AU (1) AU655838B2 (no)
BG (1) BG61189B1 (no)
CA (1) CA2077836A1 (no)
CZ (2) CZ282315B6 (no)
DE (1) DE69232216T2 (no)
DK (1) DK0531981T3 (no)
EG (1) EG20184A (no)
ES (1) ES2165351T3 (no)
FI (2) FI109127B (no)
HU (1) HU212782B (no)
IL (1) IL103109A (no)
MX (1) MX9205147A (no)
NO (1) NO301930B1 (no)
NZ (1) NZ244295A (no)
OA (1) OA09764A (no)
PH (1) PH31206A (no)
PL (1) PL174820B1 (no)
PT (1) PT531981E (no)
RO (1) RO109651B1 (no)
RU (1) RU2042681C1 (no)
SK (2) SK280934B6 (no)
UY (1) UY23475A1 (no)
YU (1) YU81692A (no)
ZA (1) ZA926866B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103110A (en) * 1991-09-10 1997-04-15 Bristol Myers Squibb Co Anhydrous process for preparing cefepime dihydrochloride hydrate
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
KR19980019860A (ko) * 1996-09-04 1998-06-25 김윤배 세팔로스포린 중간체의 신규한 제조방법
EP1618114B1 (en) * 2003-04-16 2010-07-14 Sandoz AG Processes for the preparations of cefepime
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
GB0416379D0 (en) * 2004-07-22 2004-08-25 Sandoz Ag Organic compounds
ITMI20051684A1 (it) * 2005-09-13 2007-03-14 Harvest Lodge Ltd Procedimento per la produzione del dicloridrato di amminoacidi
RU2469040C1 (ru) * 2011-12-07 2012-12-10 Общество с ограниченной ответственностью "КОМПАНИЯ "ДЕКО" Способ получения 7-[2-(2-аминотиазол-4-ил)-2(z)-метоксииминоацетамидо]-3-[(1-метил-1-пирролидино)метил]-цеф-3-ем-4-карбоксилата дигидрохлорида моногидрата (цефепима дигидрохлорида моногидрата)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
IL103110A (en) * 1991-09-10 1997-04-15 Bristol Myers Squibb Co Anhydrous process for preparing cefepime dihydrochloride hydrate

Also Published As

Publication number Publication date
HU9202884D0 (en) 1992-11-30
SK278092A3 (en) 2000-09-12
CZ71996A3 (en) 1997-06-11
IL103109A (en) 1997-07-13
UY23475A1 (es) 1992-10-08
CN1059438C (zh) 2000-12-13
HU212782B (en) 1996-11-28
NO923495D0 (no) 1992-09-09
FI119811B (fi) 2009-03-31
NZ244295A (en) 1995-08-28
NO301930B1 (no) 1997-12-29
HUT62901A (en) 1993-06-28
FI924031A (fi) 1993-03-11
BG61189B1 (bg) 1997-02-28
SK33698A3 (en) 2000-09-12
CN1070398A (zh) 1993-03-31
DE69232216T2 (de) 2002-06-27
RO109651B1 (ro) 1995-04-28
SK280933B6 (sk) 2000-09-12
BG96859A (bg) 1993-12-24
FI924031A0 (fi) 1992-09-09
EP0531981A1 (en) 1993-03-17
ATE209209T1 (de) 2001-12-15
AU655838B2 (en) 1995-01-12
NO923495L (no) 1993-03-11
PT531981E (pt) 2002-05-31
PL174820B1 (pl) 1998-09-30
IL103109A0 (en) 1993-02-21
CN1158333A (zh) 1997-09-03
SK280934B6 (sk) 2000-09-12
CZ282315B6 (cs) 1997-06-11
PH31206A (en) 1998-05-05
KR930006032A (ko) 1993-04-20
CA2077836A1 (en) 1993-03-11
DE69232216D1 (de) 2002-01-03
PL295873A1 (en) 1993-05-04
CZ278092A3 (en) 1993-03-17
FI109127B (fi) 2002-05-31
CZ282160B6 (cs) 1997-05-14
EP0531981B1 (en) 2001-11-21
JPH05194532A (ja) 1993-08-03
KR0178280B1 (ko) 1999-03-20
YU81692A (sh) 1995-03-27
AU2284492A (en) 1993-03-11
RU2042681C1 (ru) 1995-08-27
ZA926866B (en) 1993-03-09
CN1036587C (zh) 1997-12-03
FI20011921A (fi) 2001-10-01
MX9205147A (es) 1993-03-01
JP3434840B2 (ja) 2003-08-11
ES2165351T3 (es) 2002-03-16
OA09764A (fr) 1993-11-30
EG20184A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
DK0531981T3 (da) Fremgangsmåde til fremstilling af et cephalosporin-antibitiotikum
FI924032A (fi) Framstaellning av ett cefalosporinantibiotikum genom anvaendning av en syn-isomer av en tiazolylmellanprodukt
DK0581220T3 (da) Fremgangsmåde til fremstilling af cephalosporinmellemprodukter